U036 High-Yield Updates in DRESS Syndrome
DESCRIPTION
DRESS is a common condition with high morbidity and mortality. Despite this, diagnostic and treatment tools have remained constant and suboptimal, and DRESS has been treated as a homogenous condition. In this session, we define unique subtypes of DRESS with prognostic implications. We then explore how to optimize diagnosis and management using informatics tools. We then move on to review the latest guidelines for laboratory workup and monitoring, and finish by exploring modern, more-targeted therapies that have been studied in the treatment of DRESS.
LEARNING OBJECTIVES
Recognize unique DRESS subtypes and their implications
Develop a schema for ordering, interpreting, and monitoring labs in DRESS
Compare and select targeted, novel treatments for DRESS
SCHEDULE
7:30 AM
Introduction
Abraham Korman, MD, FAAD
7:35 AM
Subtypes, identifying causative drug, optimizing outcomes using electronic medical records
Abraham Korman, MD, FAAD
7:55 AM
Screening, lab interpretation, and longitudinal monitoring of extracutaneous organ involvement
Rachel Kirven, MD, FAAD
8:10 AM
Managing DRESS and the long-term psychosocial impact
Caroline Nelson, MD, FAAD
8:25 AM
Wrap up/questions
DIRECTOR
Abraham Korman, MD, FAAD
SPEAKERS
Rachel Kirven, MD, FAAD
Caroline Nelson, MD, FAAD
DISCLOSURES
Rachel Kirven, MD, FAAD
No financial relationships exist with ineligible companies.
Abraham Korman, MD, FAAD
No financial relationships exist with ineligible companies.
Caroline Nelson, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding);